Timothy P Walbert Horizon Therapeutics Public LTD CO (HZNP) insider trading activity

Timothy P Walbert is Chairman, President and CEO of Horizon Therapeutics Public Ltd Co. Currently has a direct ownership of 0 shares of HZNP, which is worth approximately $0. The most recent transaction as insider was on Jun 30, 2021, when has been sold 25,000 shares (Ordinary Shares) at a price of $94.29 per share, resulting in proceeds of $2,357,250. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

Timothy P Walbert Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 30 2021	SELL Open market or private sale	$2,357,250 $94.29 p/Share	25,000 Reduced 2.85%	850,887 Ordinary Shares
Jun 01 2021	SELL Open market or private sale	$2,290,250 $91.61 p/Share	25,000 Reduced 2.78%	875,887 Ordinary Shares
Apr 30 2021	SELL Open market or private sale	$2,366,250 $94.65 p/Share	25,000 Reduced 2.7%	899,838 Ordinary Shares
Mar 01 2021	SELL Open market or private sale	$2,471,989 $91.64 p/Share	26,975 Reduced 2.83%	924,838 Ordinary Shares
Feb 17 2021	SELL Payment of exercise price or tax liability	$364,283 $87.17 p/Share	4,179 Reduced 0.44%	951,813 Ordinary Shares
Feb 17 2021	BUY Grant, award, or other acquisition	-	9,433 Added 0.98%	955,992 Ordinary Shares
Jan 22 2021	SELL Open market or private sale	$867,115 $76.58 p/Share	11,323 Reduced 1.18%	946,559 Ordinary Shares

Jan 21 2021	SELL Payment of exercise price or tax liability	$697,412 $77.43 p/Share	9,007 Reduced 0.93%	957,882 Ordinary Shares
Jan 21 2021	BUY Exercise of conversion of derivative security	-	20,330 Added 2.06%	966,889 Ordinary Shares
Jan 15 2021	SELL Open market or private sale	$16,518,265 $78.21 p/Share	211,204 Reduced 18.24%	946,559 Ordinary Shares
Jan 05 2021	SELL Payment of exercise price or tax liability	$24,723,206 $73.28 p/Share	337,380 Reduced 22.57%	1,157,763 Ordinary Shares
Jan 05 2021	BUY Grant, award, or other acquisition	-	492,294 Added 24.77%	1,495,143 Ordinary Shares
Jan 05 2021	BUY Exercise of conversion of derivative security	-	269,057 Added 21.15%	1,002,849 Ordinary Shares
Aug 06 2020	SELL Open market or private sale	$8,064,100 $73.31 p/Share	110,000 Reduced 13.04%	733,792 Ordinary Shares
May 21 2020	SELL Bona fide gift	-	5,000 Reduced 0.59%	843,792 Ordinary Shares
Feb 21 2020	SELL Open market or private sale	$3,306,829 $35.23 p/Share	93,864 Reduced 9.97%	847,743 Ordinary Shares
Feb 19 2020	SELL Payment of exercise price or tax liability	$773,739 $36.06 p/Share	21,457 Reduced 2.23%	941,607 Ordinary Shares
Feb 19 2020	BUY Grant, award, or other acquisition	-	48,432 Added 4.79%	963,064 Ordinary Shares
Jan 21 2020	SELL Payment of exercise price or tax liability	$344,480 $38.25 p/Share	9,006 Reduced 0.98%	914,632 Ordinary Shares
Jan 21 2020	BUY Grant, award, or other acquisition	-	20,329 Added 2.15%	923,638 Ordinary Shares
Jan 06 2020	SELL Open market or private sale	$3,019,395 $35.57 p/Share	84,886 Reduced 8.59%	903,309 Ordinary Shares
Jan 05 2020	SELL Payment of exercise price or tax liability	$6,076,316 $36.1 p/Share	168,319 Reduced 14.55%	988,195 Ordinary Shares
Jan 05 2020	BUY Grant, award, or other acquisition	-	168,523 Added 12.72%	1,156,514 Ordinary Shares
Jan 05 2020	BUY Exercise of conversion of derivative security	-	211,000 Added 17.6%	987,991 Ordinary Shares
Oct 15 2019	SELL Open market or private sale	$8,971,276 $28.02 p/Share	320,174 Reduced 29.18%	776,991 Ordinary Shares

Also insider at

XCUR

EXICURE, INC. Healthcare

Director

AUPH

Aurinia Pharmaceuticals Inc. Healthcare

Director

IPSC

Century Therapeutics, Inc. Healthcare

Director

MIRM

Mirum Pharmaceuticals, Inc. Healthcare

SGMT

Sagimet Biosciences Inc.

Director

TPW